114 related articles for article (PubMed ID: 9665430)
1. Highly specific radioimmunoassay for human insulin based on immune exclusion of all insulin precursors.
Deberg M; Houssa P; Frank BH; Sodoyez-Goffaux F; Sodoyez JC
Clin Chem; 1998 Jul; 44(7):1504-13. PubMed ID: 9665430
[TBL] [Abstract][Full Text] [Related]
2. First direct assay for intact human proinsulin.
Houssa P; Dinesen B; Deberg M; Frank BH; Van Schravendijk C; Sodoyez-Goffaux F; Sodoyez JC
Clin Chem; 1998 Jul; 44(7):1514-9. PubMed ID: 9665431
[TBL] [Abstract][Full Text] [Related]
3. A direct assay for proinsulin in plasma and its applications in hypoglycaemia.
Hampton SM; Beyzavi K; Teale D; Marks V
Clin Endocrinol (Oxf); 1988 Jul; 29(1):9-16. PubMed ID: 3073882
[TBL] [Abstract][Full Text] [Related]
4. A sensitive and reliable method for assaying true human insulin without interaction with human proinsulin-like molecules.
Monti LD; Sandoli EP; Phan VC; Piatti PM; Costa S; Secchi A; Pozza G
Acta Diabetol; 1995 Mar; 32(1):57-63. PubMed ID: 7612920
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immunoassays for insulin in diagnostic tests for insulinoma.
Shimizu T; Sasakuma F; Ishikawa O; Matsumiya K; Hasegawa K; Sasaki A
Diabetes Res Clin Pract; 1994 Dec; 26(2):149-54. PubMed ID: 7705197
[TBL] [Abstract][Full Text] [Related]
6. A soluble-phase proinsulin radioimmunoassay and its use in diagnosis of hypoglycaemia.
Naylor BA; Matthews DR; Turner RC
Ann Clin Biochem; 1987 Jul; 24 ( Pt 4)():352-63. PubMed ID: 3310832
[TBL] [Abstract][Full Text] [Related]
7. Recognition of human insulin and proinsulin by monoclonal antibodies.
Storch MJ; Petersen KG; Licht T; Kerp L
Diabetes; 1985 Aug; 34(8):808-11. PubMed ID: 3894122
[TBL] [Abstract][Full Text] [Related]
8. Characterization and use in immunoradiometric assay of monoclonal antibodies directed against human proinsulin.
Gray IP; Siddle K; Frank BH; Hales CN
Diabetes; 1987 Jun; 36(6):684-8. PubMed ID: 2436963
[TBL] [Abstract][Full Text] [Related]
9. [Insulinoma with hyperproinsulinemia: a two cases report].
Gury H; Rio F; Neamtu D; Boivin S
Ann Endocrinol (Paris); 2002 Jun; 63(3):240-2. PubMed ID: 12193882
[TBL] [Abstract][Full Text] [Related]
10. A radioimmunoassay for circulating human proinsulin.
Cohen RM; Nakabayashi T; Blix PM; Rue PA; Shoelson SE; Root MA; Frank BH; Revers RR; Rubenstein AH
Diabetes; 1985 Jan; 34(1):84-91. PubMed ID: 3880551
[TBL] [Abstract][Full Text] [Related]
11. The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.
Guettier JM; Lungu A; Goodling A; Cochran C; Gorden P
J Clin Endocrinol Metab; 2013 Dec; 98(12):4752-8. PubMed ID: 24081736
[TBL] [Abstract][Full Text] [Related]
12. A sensitive radioimmunoassay for human proinsulin, with sequential use of antisera to C-peptide and insulin.
Ward WK; Paquette TL; Frank BH; Porte D
Clin Chem; 1986 May; 32(5):728-33. PubMed ID: 3516448
[TBL] [Abstract][Full Text] [Related]
13. Plasma proinsulin-like component in insulinoma: a 25-year experience.
Gorden P; Skarulis MC; Roach P; Comi RJ; Fraker DL; Norton JA; Alexander HR; Doppman JL
J Clin Endocrinol Metab; 1995 Oct; 80(10):2884-7. PubMed ID: 7559869
[No Abstract] [Full Text] [Related]
14. The production and characterization of monoclonal antibodies specific for human proinsulin using a sensitive microdot assay procedure.
Madsen OD; Cohen RM; Fitch FW; Rubenstein AH; Steiner DF
Endocrinology; 1983 Dec; 113(6):2135-44. PubMed ID: 6196183
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the determination of insulin by a monoclonal antibody-based immunofluorometric assay and by radioimmunoassay.
Vieira JG; Nishida SK; Lombardi MT; Tachibana TT; Obara LH; Dalbosco IS; Russo EM
Braz J Med Biol Res; 1995 May; 28(5):537-43. PubMed ID: 8555973
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies.
Kjems LL; Røder ME; Dinesen B; Hartling SG; Jørgensen PN; Binder C
Clin Chem; 1993 Oct; 39(10):2146-50. PubMed ID: 8403400
[TBL] [Abstract][Full Text] [Related]
17. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
Kahn SE; Halban PA
Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
[TBL] [Abstract][Full Text] [Related]
18. Measurement of circulating human proinsulin concentrations using a proinsulin-specific antiserum.
Deacon CF; Conlon JM
Diabetes; 1985 May; 34(5):491-7. PubMed ID: 3886462
[TBL] [Abstract][Full Text] [Related]
19. Separation of the two double-chain bovine intermediates of the proinsulin-insulin conversion I. Chemical, immunochemical, circular dichroism, and biological characterization.
Markussen J; Heding LG
Int J Pept Protein Res; 1976; 8(6):597-606. PubMed ID: 992943
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and clinical implications of proinsulin conversion intermediates.
Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
